Back to results
US 8,784,841 B2Granted
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
AssigneeIpsen Pharma S.A.S.
InventorsChristine Favre, Michel Auguet, Piere-Etienne Chabrier De Lassauniere
Life of this patent
Estimating the term…
Abstract
The present invention relates to at least one botulinum neurotoxin for treatment of prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration.
Claims13
A method of treating pain associated with diabetic neuropathy comprising administering at least one botulinum neurotoxin to a painless site in the upper or lower limb to a subject in need thereof,
- wherein said administration alleviates pain on the contralateral side of the body, distant from the site of administration, and said botulinum neurotoxin is not administered to the central nervous system, thereby alleviating pain on the contralateral side of the body.
Dependencies are inferred from the claim text.